Synergism between 2,3,7,8-tetrachlorodibenzo-p-dioxin and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone on lung tumor incidence in mice

Journal of Hazardous Materials

Volumn 186, Issue 1, 2011, Pages 869-875

  Wang, Ying Jan ^a   Chang, Han ^b   Kuo, Yu Chun ^c   Wang, Chien Kai ^c   Siao, Shih He ^a   Chang, Louis W ^c   Lin, Pinpin ^c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin; Lung cancer; P16

Indexed keywords

HUMAN CARCINOGEN; IMMUNOHISTOCHEMICAL STAINING; LUNG CANCER; LUNG TUMOR; OXIDATIVE DNA DAMAGE; P16; PYRIDYL; REAL TIME RT-PCR; REPEATED APPLICATION; SYNERGISTIC EFFECT; TETRACHLORODIBENZO P DIOXINS; TUMORIGENESIS;

DISEASES; KETONES; NUCLEIC ACIDS; POLYMERASE CHAIN REACTION; TUMORS;

BIOLOGICAL ORGANS;

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BACULOVIRAL IAP REPEAT CONTAINING 5 PROTEIN; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; CALVASCULIN; CASPASE 8; CD146 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR 54; GELATINASE B; MESSENGER RNA; METASTASIS ASSOCIATED GENE FAMILY MEMBER 2 PROTEION; MYC PROTEIN; NERVE CELL ADHESION MOLECULE; NONMETASTATIC CELLS 4 PROTEIN; PLASMINOGEN ACTIVATOR; PROTEIN; PROTEIN C JUN; PROTEIN FOS; PROTEIN P16; SCATTER FACTOR; TRANSCRIPTION FACTOR TWIST; TRANSFORMATION RELATED PROTEIN 53; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10B; UNCLASSIFIED DRUG;

CARCINOGEN; GENETIC ANALYSIS; KETONE; POLYMERASE CHAIN REACTION; RODENT; SYNERGISM; TCDD; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CARCINOGENIC ACTIVITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LUNG ADENOMA; MALE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REPEAT PROCEDURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

ANIMALS; CARCINOGENS; FEMALE; GENES, P16; IMMUNOHISTOCHEMISTRY; INCIDENCE; LUNG NEOPLASMS; MALE; MICE; NITROSAMINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRACHLORODIBENZODIOXIN;

MUS;

EID: 79551516169     PISSN: 03043894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2010.11.082     Document Type: Article

References (42)

1. Kogevinas M. Studies of cancer in humans. Food Addit. Contam. 2000, 17:317-324.
2. Steenland K., Bertazzi P., Baccarelli A., Kogevinas M. Dioxin revisited: developments since the 1997 IARC classification of dioxin as a human carcinogen. Environ. Health Perspect. 2004, 112:1265-1268.
3. Walker N.J., Wyde M.E., Fischer L.J., Nyska A., Bucher J.R. Comparison of chronic toxicity and carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in 2-year bioassays in female Sprague-Dawley rats. Mol. Nutr. Food Res. 2006, 50:934-944.
4. Gasiewicz T.A., Henry E.C., Collins L.L. Expression and activity of aryl hydrocarbon receptors in development and cancer. Crit. Rev. Eukaryot. Gene Expr. 2008, 18:279-321.
5. Cole P., Trichopoulos D., Pastides H., Starr T., Mandel J.S. Dioxin and cancer: a critical review. Regul. Toxicol. Pharmacol. 2003, 38:378-388.
6. Schrader E., Hirsch-Ernst K.I., Scholz E., Kahl G.F., Foth H. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in primary cultures of rat alveolar type II cells. Drug Metab. Disp. 2000, 28:180-185.
7. R.K. Lin, Y.S. Hsieh, P. Lin, H.S. Hsu, C.Y. Chen, Y.A. Tang, C.F. Lee, Y.C. Wang, The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients, J. Clin. Investig. 120, 521-532.
8. Ray S.S., Swanson H.I. Dioxin-induced immortalization of normal human keratinocytes and silencing of p53 and p16INK4a. J. Biol. Chem. 2004, 279:27187-27193.
9. Tritscher A.M., Seacat A.M., Yager J.D., Groopman J.D., Miller B.D., Bell D., Sutter T.R., Lucier G.W. Increased oxidative DNA damage in livers of 2,3,7,8-tetrachlorodibenzo-p-dioxin treated intact but not ovariectomized rats. Cancer Lett. 1996, 98:219-225.
10. Wyde M.E., Wong V.A., Kim A.H., Lucier G.W., Walker N.J. Induction of hepatic 8-oxo-deoxyguanosine adducts by 2,3,7,8-tetrachlorodibenzo-p-dioxin in Sprague-Dawley rats is female-specific and estrogen-dependent. Chem. Res. Toxicol. 2001, 14:849-855.
11. Laurent A., Nicco C., Chereau C., Goulvestre C., Alexandre J., Alves A., Levy E., Goldwasser F., Panis Y., Soubrane O., Weill B., Batteux F. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res. 2005, 65:948-956.
12. Klaunig J.E., Xu Y., Isenberg J.S., Bachowski S., Kolaja K.L., Jiang J., Stevenson D.E., Walborg E.F. The role of oxidative stress in chemical carcinogenesis. Environ. Health Perspect. 1998, 106(Suppl. 1):289-295.
13. Knerr S., Schrenk D. Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in experimental models. Mol. Nutr. Food Res. 2006, 50:897-907.
14. Beebe L.E., Anver M.R., Riggs C.W., Fornwald L.W., Anderson L.M. Promotion of N-nitrosodimethylamine-initiated mouse lung tumors following single or multiple low dose exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis 1995, 16:1345-1349.
15. Schwarz M., Appel K.E. Carcinogenic risks of dioxin: mechanistic considerations. Regul. Toxicol. Pharmacol. 2005, 43:19-34.
16. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 1999, 91:1194-1210.
17. Belinsky S.A., Devereux T.R., Foley J.F., Maronpot R.R., Anderson M.W. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res. 1992, 52:3164-3173.
18. Funseth E., Ilback N.G. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on blood and spleen natural killer (NK) cell activity in the mouse. Toxicol. Lett. 1992, 60:247-256.
19. Villano C.M., Murphy K.A., Akintobi A., White L.A. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells. Toxicol. Appl. Pharmacol. 2006, 210:212-224.
20. Diry M., Tomkiewicz C., Koehle C., Coumoul X., Bock K.W., Barouki R., Transy C. Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism. Oncogene 2006, 25:5570-5574.
21. Ray S., Swanson H.I. Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event. Biochem. Pharmacol. 2009, 77:681-688.
22. Takeuchi H., Saoo K., Yokohira M., Ikeda M., Maeta H., Miyazaki M., Yamazaki H., Kamataki T., Imaida K. Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Cancer Res. 2003, 63:7581-7583.
23. A. Braun, H. Ernst, H.G. Hoymann, S. Rittinghausen, The Laboratory Mouse, Elseriver Academic Press, London, 2004.
24. Lin P., Chang H., Ho W.L., Wu M.H., Su J.M. Association of aryl hydrocarbon receptor and cytochrome P4501B1 expressions in human non-small cell lung cancers. Lung Cancer 2003, 42:255-261.
25. Begum S., Gillison M.L., Nicol T.L., Westra W.H. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin. Cancer Res. 2007, 13:1186-1191.
26. Lee H.L., Hsueh Y.M., Chung C.J., Pu Y.S., Chang L.W., Hsieh D.P., Liou S.H., Lin P. Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients. Cancer Epidemiol. Biomarkers Prev. 2008, 17:3390-3395.
27. Hecht S.S., Carmella S.G., Le K.A., Murphy S.E., Boettcher A.J., Le C., Koopmeiners J., An L., Hennrikus D.J. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides in the urine of infants exposed to environmental tobacco smoke. Cancer Epidemiol. Biomarkers Prev. 2006, 15:988-992.
28. Nakamura T., Nakai K., Matsumura T., Suzuki S., Saito Y., Satoh H. Determination of dioxins and polychlorinated biphenyls in breast milk, maternal blood and cord blood from residents of Tohoku, Japan. Sci. Total Environ. 2008, 394:39-51.
29. Wang S.L., Lin C.Y., Guo Y.L., Lin L.Y., Chou W.L., Chang L.W. Infant exposure to polychlorinated dibenzo-p-dioxins, dibenzofurans and biphenyls (PCDD/Fs PCBs)-correlation between prenatal and postnatal exposure. Chemosphere 2004, 54:1459-1473.
30. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8:729-740.
31. Krimpenfort P., Quon K.C., Mooi W.J., Loonstra A., Berns A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 2001, 413:83-86.
32. Sharpless N.E., Bardeesy N., Lee K.H., Carrasco D., Castrillon D.H., Aguirre A.J., Wu E.A., Horner J.W., DePinho R.A. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 2001, 413:86-91.
33. Wikenheiser-Brokamp K.A. Retinoblastoma regulatory pathway in lung cancer. Curr. Mol. Med. 2006, 6:783-793.
34. Tanaka R., Wang D., Morishita Y., Inadome Y., Minami Y., Iijima T., Fukai S., Goya T., Noguchi M. Loss of function of p16 gene and prognosis of pulmonary adenocarcinoma. Cancer 2005, 103:608-615.
35. Belinsky S.A. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat. Rev. Cancer 2004, 4:707-717.
36. Dammann R., Strunnikova M., Schagdarsurengin U., Rastetter M., Papritz M., Hattenhorst U.E., Hofmann H.S., Silber R.E., Burdach S., Hansen G. CpG island methylation and expression of tumour-associated genes in lung carcinoma. Eur. J. Cancer 2005, 41:1223-1236.
37. Russo A.L., Thiagalingam A., Pan H., Califano J., Cheng K.H., Ponte J.F., Chinnappan D., Nemani P., Sidransky D., Thiagalingam S. Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin. Cancer Res. 2005, 11:2466-2470.
38. Feng Y., Wang X., Xu L., Pan H., Zhu S., Liang Q., Huang B., Lu J. The transcription factor ZBP-89 suppresses p16 expression through a histone modification mechanism to affect cell senescence. FEBS J. 2009, 276:4197-4206.
39. Cameron E.E., Bachman K.E., Myohanen S., Herman J.G., Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 1999, 21:103-107.
40. Munro J., Barr N.I., Ireland H., Morrison V., Parkinson E.K. Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock. Exp. Cell Res. 2004, 295:525-538.
41. Belinsky S.A., Swafford D.S., Middleton S.K., Kennedy C.H., Tesfaigzi J. Deletion and differential expression of p16INK4a in mouse lung tumors. Carcinogenesis 1997, 18:115-120.
42. Belinsky S.A. Role of the cytosine DNA-methyltransferase and p16INK4a genes in the development of mouse lung tumors. Exp. Lung Res. 1998, 24:463-479.